BR112022007332A2 - Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit - Google Patents

Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit

Info

Publication number
BR112022007332A2
BR112022007332A2 BR112022007332A BR112022007332A BR112022007332A2 BR 112022007332 A2 BR112022007332 A2 BR 112022007332A2 BR 112022007332 A BR112022007332 A BR 112022007332A BR 112022007332 A BR112022007332 A BR 112022007332A BR 112022007332 A2 BR112022007332 A2 BR 112022007332A2
Authority
BR
Brazil
Prior art keywords
eye
well
eye device
dispensing
box
Prior art date
Application number
BR112022007332A
Other languages
English (en)
Inventor
E Labombard Denis
Original Assignee
E Labombard Denis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Labombard Denis filed Critical E Labombard Denis
Publication of BR112022007332A2 publication Critical patent/BR112022007332A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0095—Packages or dispensers for prostheses or other implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/04—Homopolymers or copolymers of ethene
    • C08L23/08—Copolymers of ethene
    • C08L23/0846—Copolymers of ethene with unsaturated hydrocarbons containing other atoms than carbon or hydrogen atoms
    • C08L23/0853—Vinylacetate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
    • C08L23/10—Homopolymers or copolymers of propene
    • C08L23/12—Polypropene
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Prostheses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DISPOSITIVO OCULAR, MÉTODOS, COMPOSIÇÃO, CAIXA PARA CONTER E DISPENSAR UM DISPOSITIVO OCULAR E KIT. A presente invenção se refere a um dispositivo ocular para colocação sob uma pálpebra que inclui uma placa com uma superfície posterior tendo pelo menos uma projeção que apresenta uma superfície de contato convexa para fazer contato com a esclera do olho e para prover um espaço de deslocamento. A placa pode ser conectada em um elemento de suporte alongado. O dispositivo ocular pode distribuir um material para um olho de um usuário, incluindo, por exemplo, um agente farmaceuticamente ativo. Uma caixa para conter e dispensar um dispositivo ocular inclui um poço configurado para reter fluido, um estabilizador e uma tampa. A tampa é conectada no poço e girável entre uma posição que cobre o poço e uma posição com o poço não coberto. A tampa pode apresentar um orifício para adicionar fluido no poço, e um receptor, que pode reter um dispositivo ocular, pode se projetar a partir da tampa.
BR112022007332A 2019-10-24 2020-10-21 Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit BR112022007332A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962925695P 2019-10-24 2019-10-24
PCT/US2020/056700 WO2021081117A2 (en) 2019-10-24 2020-10-21 Ocular device and drug delivery system, with case

Publications (1)

Publication Number Publication Date
BR112022007332A2 true BR112022007332A2 (pt) 2022-07-05

Family

ID=73288711

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022007332A BR112022007332A2 (pt) 2019-10-24 2020-10-21 Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit

Country Status (11)

Country Link
US (1) US20210121324A1 (pt)
EP (1) EP4048212A2 (pt)
JP (1) JP2022553408A (pt)
KR (1) KR20220088726A (pt)
CN (1) CN114555017A (pt)
AU (1) AU2020371620A1 (pt)
BR (1) BR112022007332A2 (pt)
CA (1) CA3149866A1 (pt)
IL (1) IL291479A (pt)
MX (1) MX2022004633A (pt)
WO (1) WO2021081117A2 (pt)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186540A (en) * 1962-05-24 1965-06-01 Joseph L Breger Contact lens container
US3302646A (en) 1964-01-10 1967-02-07 Charles A Behney Apparatus for treating eye infection
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US4309996A (en) 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4889693A (en) * 1988-01-22 1989-12-26 Ciba-Geigy Corporation Apparatus for venting of gases from contact lens cases
EP0443809A3 (en) * 1990-02-20 1992-04-15 Ioptex Research Inc. Coated intraocular lens and coatings therefor
WO1993019707A1 (en) * 1992-04-02 1993-10-14 Bausch & Lomb Incorporated Ophthalmic article
US5515964A (en) * 1995-04-13 1996-05-14 Bauman; Robert C. Contact lens package with lens retaining recess
US5756044A (en) * 1996-04-09 1998-05-26 Ciba Vision Corporation Apparatus and method for treating articles in solution with effervescent tablets
US6071266A (en) 1996-04-26 2000-06-06 Kelley; Donald W. Lubricious medical devices
US7906143B1 (en) * 1998-10-05 2011-03-15 Intellipharmaceutics Corp Controlled release pharmaceutical delivery device and process for preparation thereof
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
AU2001289038B2 (en) * 2000-09-12 2006-05-18 Revision Optics, Inc. System for packaging and handling an implant and method of use
US8167855B2 (en) 2003-08-26 2012-05-01 Vista Scientific Llc Ocular drug delivery device
US7211272B2 (en) 2003-12-22 2007-05-01 Bausch & Lomb Incorporated Drug delivery device
US8923961B2 (en) * 2006-10-18 2014-12-30 The Cleveland Clinic Foundation Electrode assembly for delivering a therapeutic agent into ocular tissue
US20090162417A1 (en) * 2007-12-21 2009-06-25 Cook Incorporated Drug eluting ocular conformer
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
US20120130300A1 (en) 2009-07-14 2012-05-24 Board Of Regents, The Univerity Of Texas System Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
US20120109082A1 (en) * 2010-10-29 2012-05-03 Vista Scientific Llc Devices for delivering at least one active agent to tissue
ES2370014B2 (es) * 2011-07-19 2012-03-30 Universidad Politecnica De Madrid Dispositivo ocular.
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
RU2669407C2 (ru) 2013-03-15 2018-10-11 ТАРИС Биомедикал ЛЛК Устройства для доставки лекарственных средств и способы доставки лекарственных средств
CN106604695B (zh) 2014-09-06 2018-10-23 整体生物系统有限责任公司 用于在眼中实现持续药物释放的方法和生物相容性组合物
KR20200019864A (ko) * 2017-05-08 2020-02-25 인메드 파마슈티컬스 인코포레이티드 안구용 약물 전달 제형

Also Published As

Publication number Publication date
WO2021081117A3 (en) 2021-06-17
MX2022004633A (es) 2022-09-29
AU2020371620A1 (en) 2022-03-31
JP2022553408A (ja) 2022-12-22
EP4048212A2 (en) 2022-08-31
IL291479A (en) 2022-05-01
WO2021081117A2 (en) 2021-04-29
US20210121324A1 (en) 2021-04-29
KR20220088726A (ko) 2022-06-28
CN114555017A (zh) 2022-05-27
CA3149866A1 (en) 2021-04-29

Similar Documents

Publication Publication Date Title
ES2533359T3 (es) Núcleos de fármaco para liberación sostenida de agentes terapéuticos
BR0210287A (pt) Dispositivo de administração de droga oftalmológica
Tham et al. Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG)
WO2017158365A3 (en) Ophthalmic delivery device and ophthalmic active agent containing compositions
BRPI0607027A2 (pt) dispositivo de injeção
BR0210494A (pt) Dispositivo de administração de droga oftálmica
BRPI0413381A (pt) composições para liberação de compostos terapêuticos nos olhos e processos para fabricação e uso das mesmas
RU2010142353A (ru) Водные фармацевтические композиции, содержащие борат-полиольные комплексы
CN107949356A (zh) 用于玻璃体视网膜手术的接触透镜安装窥器
WO2006119258A3 (en) Use of hydrogen sulfide in the treatment of eye diseases
US10856969B2 (en) Toric intraocular lens and intraocular lens insertion apparatus
Huh et al. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery
BRPI0705304A (pt) tampões para abertura para a distribuição de agentes ativos
BR0110156A (pt) Bocal interno em uma peça e dispositivo de aperto para um bocal interno
Mehdizadeh et al. Dome-shaped macula in eyes with myopic posterior staphyloma
BR112022007332A2 (pt) Dispositivo ocular, métodos, composição, caixa para conter e dispensar um dispositivo ocular e kit
BR102013015381A2 (pt) implante escleral epimacular
KR20160062637A (ko) 투입이 용이한 안약 용기
Murugesan et al. Evaluation of corneal biomechanical properties following penetrating keratoplasty using ocular response analyzer
BRPI1012785A2 (pt) bujão antigota com tampa móvel comandada elasticamente
BR112019000204A2 (pt) óptica central de dureza aumentada em lentes de contato macias para correção de astigmatismo
JP2019122566A (ja) 点眼液容器
BR112023006371A2 (pt) Composição oftalmológica tópica
AR070466A1 (es) Composiciones de gemifloxacina oculares, procedimiento de preparacion y uso
BRPI0704592A (pt) tampões para abertura para a distribuição de agentes ativos